CRISPR Therapeutics AG (CRSP)

NASDAQ: CRSP · Real-Time Price · USD

37.73

-0.94 (-2.43%)

At close: May 01, 2025, 3:59 PM

38.35

1.63%

Pre-market: May 02, 2025, 09:05 AM EDT

CRISPR Therapeutics Income Statement

Financials in USD. Fiscal year is January - December.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Period Ending	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019	Dec 31, 2018	Dec 31, 2017	Dec 31, 2016
Revenue	35M	371.21M	436K	913.08M	543K	289.59M	3.12M	41M	5.16M
Cost of Revenue	-2.31M	130.25M	110.25M	17.95M	269.41M	179.36M	113.77M	69.8M	42.24M
Gross Profit	37.31M	240.96M	-109.81M	895.13M	-268.86M	110.23M	-110.65M	-28.8M	-37.07M
Operating Income	-466.57M	-222.54M	-673.16M	373.53M	-354.44M	46.74M	-158.94M	-64.65M	-68.13M
Interest Income	n/a	n/a	n/a	n/a	n/a	10.03M	n/a	n/a	n/a
Pretax Income	-362.67M	-150.72M	-650.5M	379.53M	-348.06M	67.31M	-164.43M	-66.61M	-22.72M
Net Income	-366.25M	-153.61M	-650.17M	377.66M	-348.87M	66.86M	-164.98M	-68.36M	-23.2M
Selling & General & Admin	72.98M	76.16M	102.46M	102.8M	88.21M	63.49M	48.29M	35.84M	31.06M
Research & Development	320.65M	387.33M	461.64M	438.63M	266.95M	179.36M	113.77M	69.8M	42.24M
Other Expenses	110.25M	-1.21M	-762K	-1.88M	-176K	20.57M	-5.49M	-197K	78.51M
Operating Expenses	503.88M	462.29M	563.35M	539.55M	354.98M	242.85M	162.07M	105.64M	73.29M
Interest Expense	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	8.05M
Selling & Marketing Expenses	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Cost & Expenses	501.57M	593.74M	673.6M	539.55M	354.98M	242.85M	162.07M	105.64M	73.29M
Income Tax Expense	3.59M	2.89M	-325K	1.87M	809K	448K	553K	1.75M	484K
Shares Outstanding (Basic)	84.36M	79.22M	77.75M	75.95M	65.95M	54.39M	47.96M	39.97M	12.26M
Shares Outstanding (Diluted)	84.36M	79.22M	77.75M	80.39M	65.95M	56.93M	47.96M	40.06M	12.26M
EPS (Basic)	-4.34	-1.94	-8.36	4.97	-5.29	1.23	-3.44	-1.71	-1.89
EPS (Diluted)	-4.34	-1.94	-8.36	4.70	-5.29	1.17	-3.44	-1.71	-1.89
EBITDA	-466.57M	-202.7M	-648.99M	391.48M	-345.25M	51.47M	-155.42M	-61.62M	-13.67M
EBIT	-466.57M	-222.54M	-673.16M	373.53M	-354.44M	46.74M	-158.94M	-64.65M	-14.67M
Depreciation & Amortization	19.26M	19.84M	24.17M	17.95M	9.18M	4.72M	3.52M	3.02M	1M